Data driving your clinical decisions
The UltimasterTM Clinical Program included one of the largest, prospective worldwide registries, the e- ULTIMASTER™ with 37,198 patients. The Ultimaster™ Clinical Program² demonstrates the safe and effective use of the Ultimaster stent in different patient cohorts, representative of daily PCI practice.
Total Population
- 37,178 patients enrolled in the e-ULTIMASTER™ registry, one of the largest, prospective worldwide registries.
- e-ULTIMASTER™– a truly all comer's DES clinical registry.
Complex PCI
- e-ULTIMASTER™ all-comer registry enrolled more than 10,000 patients meeting complex PCI criteria.
- Complex PCI was defined as:
- Multivessel PCI > 3 stents implanted > 3 lesions treated.
- Bifurcation PCI with > 2 stents, total stent length > 60mm and chronic total occlusion.
Bifurcation
- 4,395 patients with bifurcation lesions treated with Ultimaster™ DES showed excellent clinical outcomes with TLF of 5.1% at 1 year.
- Use of the proximal optimization technique (POT) was associated with a better clinical outcome with respect to TLF and TVF at 1 year. This was due to a strong impact on the risk of TV-MI, stent thrombosis and revascularisation.
Multivessel Disease- The revascularization strategy (complete versus incomplete revascularization) in multivessel disease patients treated with Ultimaster™ DES was assessed at 1-year follow-up.
- Complete revascularization was associated with better relief from angina, lower mortality, less target vessel failure (TVF), and lower patient oriented composite endpoint (POCE).
- Ultimaster™ DES demonstrated excellent results in this complex population.
